The human filarial parasite Brugia malayi harbors an endosymbiotic bacterium Wolbachia (wBm) that is required for parasite survival. Consequently, targeting wBm is a promising approach for anti-filarial drug development. The Type IV secretion system (T4SS) plays an important role in bacteria-host interactions and is under stringent regulation by transcription factors. In wBm, most T4SS genes are contained in two operons. We show the wBm is active since the essential assembly factor virB8-1, is transcribed in adult worms and larval stages, and VirB8-1 is present in parasite lysates. We also identify two transcription factors (wBmxR1 and wBmxR2) that bind to the promoter region of several genes of the T4SS. Gel shift assays show binding of wBmxR1 to regions upstream of the virB9-2 and wBmxR2 genes, whereas wBmxR2 binds to virB4-2 and wBmxR1 promoter regions. Interestingly, both transcription factors bind to the promoter of the ribA gene that precedes virB8-1, the first gene in operon 1 of the wBm T4SS. RT-PCR reveals ribA and virB8-1 genes are co-transcribed as one operon, indicating the ribA gene and T4SS operon 1 are co-regulated by both wBmxR1 and wBmxR2. RibA encodes a bi-functional enzyme that catalyzes two essential steps in riboflavin (Vitamin B2) biosynthesis. Importantly, the riboflavin pathway is absent in B. malayi. We demonstrate the pathway is functional in wBm, and observe vitamin B2 supplementation partially rescues filarial parasites treated with doxycycline, indicating Wolbachia may supply the essential vitamin to its worm host. This is the first characterization of a transcription factor(s) from wBm and first report of co-regulation of genes of the T4SS and riboflavin biosynthesis pathway. In addition, our results demonstrate a requirement of vitamin B2 for worm health and fertility, and imply a nutritional role of the symbiont for the filarial parasite host.
Citation: Li Z, Carlow CKS (2012) Characterization of Transcription Factors That Regulate the Type IV Secretion System and Riboflavin Biosynthesis in Wolbachia of Brugia malayi. PLoS ONE 7(12): e51597. doi:10.1371/journal.pone.0051597
Editor: Matty Knight, Biomedical Research Institute, United States of America
Received: September 14, 2012; Accepted: November 8, 2012; Published: December 10, 2012
Copyright: © 2012 Li, Carlow. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have the following interests. All authors are employed by New England Biolabs, the funder of this study. Clotilde Carlow is a PLOS ONE Editorial Board member. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Lymphatic filariasis and onchocerciasis are neglected tropical diseases caused by filarial nematode parasites. Brugia malayi and Wuchereria bancrofti reside in the lymphatics resulting in lymphedema, hydrocele and elephantiasis. Infection with Onchocerca volvulus leads to dermatitis and blindness. Collectively, these severely debilitating diseases afflict 150 million people in the tropics and threaten the health of over one billion. The parasites contain an α-proteobacterial endosymbiont belonging to the genus Wolbachia, where the bacterium is an obligate mutualist required for development, reproduction and survival of the parasite , , , . There has been considerable interest in filarial Wolbachia since antibiotic-mediated clearance of Wolbachia from the parasite correlates with a block in embryogenesis, worm death and improvement in disease symptoms , , , , .
Wolbachia is also highly prevalent in insects with an estimated 20–80% of arthropod species infected , , , , including those that transmit human filarial parasites . Wolbachia-host interactions in insects are complex and infection can result in a number of developmental and reproductive abnormalities , , . Currently little is known about the molecular and/or biochemical basis of the interactions that exist between Wolbachia and its insect or nematode host. This is of great interest given the major effects on host biology and the possibility of exploiting the symbiotic relationship as a target for new drug discovery.
Many symbiotic and pathogenic intracellular bacteria use a type IV secretion system (T4SS) for successful infection, proliferation and persistence within hosts , , . The T4SS of gram-negative bacteria is a trans-membrane channel composed of several conserved proteins that can transport effector molecules across the membrane into the cytoplasm or nucleus of eukaryotic cells in an ATP-dependent manner . The system is present and highly conserved in insect Wolbachia , , , , which may implicate its importance in the host-symbiont interaction and survival of bacteria within host cells. Genome analysis predicts the presence of a T4SS in the Wolbachia present in B. malayi (wBm), suggesting that the system is also likely active in filarial Wolbachia . Previous studies in other bacteria have shown that the T4SS is not constitutively expressed but tightly regulated by transcription factors , , , . In the intracellular rickettsial pathogen Ehrlichia chaffeensis, a transcription factor EcxR has been identified which binds to the promoter regions upstream of virBD genes of the T4SS, as well as its own promoter, and positively regulates their expression in a developmental stage-specific manner .
In the present study, we demonstrate wBm has an active T4SS since the essential assembly factor virB8-1, is transcribed in adult worms and larval stages, and VirB8-1 is present in parasite lysates. We also identify two transcription factors that regulate T4SS gene expression. Interestingly both transcription factors also bind to the promoter of the ribA gene located upstream of virB8-1, the first gene in operon 1 of the wBm T4SS. We show ribA and virB8-1 genes are co-transcribed as one operon, indicating the ribA gene and T4SS operon 1 are co-regulated. RibA encodes a bifunctional enzyme that catalyzes two essential steps in riboflavin (vitamin B2) biosynthesis. While the riboflavin pathway is absent from B. malayi, we demonstrate the pathway is expressed in wBm. We find vitamin B2 supplementation partially rescues parasites treated with doxycycline, indicating Wolbachia may supply the essential vitamin to its worm host.
Materials and Methods
Identification of orthologs of EcxR in wBm
To identify homolog(s) of Ehrlichia EcxR, protein sequence ECH_0795 (YP_507593) was used to query the genome of the endosymbiotic bacteria Wolbachia (wBm) of B. malayi and Wolbachia of Drosophila melanogaster (wMel). Protein alignment was performed using the TCOFFEE ClustalW alignment software (http://tcoffee.vital-it.ch/cgi-bin/Tcoffee/tcoffee_cgi/index.cgi) and displayed using BOXSHADE (www.ch.embnet.org/software/BOX_form.html). A phylogenetic tree was generated using ClustalW (http://align.genome.jp/sit-bin/clustalw). A protein blast search was performed to identify putative conserved domains belonging to the HXT_XRE superfamily of cl15761 that includes DNA binding proteins belonging to the xenobiotic response element family of transcriptional regulators. Protein structure prediction was performed using the PHYRE program . Helix-turn-helix structure analysis was based on the structure of 2o38_A, a putative Xre family transcriptional regulator from the alpha-proteobacterium Rhodopseudomonas palustris CGA009. Sequence identity values between two sequences were generated using BlastP.
Quantitative RT-PCR to determine gene expression in various developmental stages of B. malayi
Total B. malayi RNA supplied by the Filariasis Research Resource Center (FR3) was treated with RNase-free Dnase (New England Biolabs, NEB) and purified using the RNeasy Kit from Qiagen. cDNA was obtained using random primers and M-MuLV reverse transcriptase (RT+) (NEB). Reactions containing no reverse transcriptase were included to detect potential DNA contamination of the RNA sample. Forward and reverse primers listed in Table 1 were used to amplify the desired sequences. Wolbachia 16S rRNA was used for bacterial total RNA quantification. Quantitative PCR was performed using the DyNAmo™ HS SYBR® Green qPCR Kit (Thermo Fisher) and a CFX-96 Real Time PCR instrument (Bio-rad). To determine temporal gene expression in bacteria, quantification of the 16S rRNA is often used as a reference , therefore gene expression levels were calculated relative to 16S rRNA as previously described . To detect expression of the intergenic region between ribA and virB8, PCR products were loaded onto a 1.2% agarose gel and stained with ethidium bromide.
Cloning, expression and purification of recombinant proteins
Living B. malayi adult female worms were purchased from TRS Laboratories, Athens GA. Genomic DNA was isolated following the protocols developed by Dr. Steven A. Williams (http://www.filariasiscenter.org/molecular-resources/protocols).
Genes were amplified using genomic DNA isolated from B. malayi. Primers (Table 2) were synthesized according to the various gene sequences. Genes were cloned into the corresponding restriction enzyme sites of pET21a. The accuracy of the inserts was verified by sequencing. Plasmids were transformed into T7 express E. coli strain C2526 (NEB) for protein expression. For wBmxR2, optimum conditions for production of soluble recombinant proteins involved co-transformation of the pRIL plasmid (Agilent) together with wBmxR2-pET21a plasmids. Cultures were grown at 37°C till the OD600 reached 0.6, followed by induction with 0.1 mM IPTG overnight at 16°C. The cells expressing the recombinant proteins were suspended in lysis buffer (20 mM NaPO4, 500 mM NaCl, 10 mM imidazole, pH 7.4) plus 1 mg/mL lysozyme and protease inhibitor cocktail (Roche) and incubated on ice for 30 min, followed by sonication. The lysate was then cleared by centrifugation at 21,000 g, for 30 min at 4°C. The C terminus His6-tagged proteins were purified on a 5 ml HisTrap HP column (GE Healthcare) using an AKTA FPLC following manufacturer's instructions. After application of the sample, the column was washed with 5 column volumes of buffer A (20 mM NaPO4, 200 mM NaCl, 10 mM imidazole, pH 7.4) followed by 10 column volumes of 84% buffer A:16% buffer B (20 mM NaPO4, 500 mM NaCl, 400 mM imidazole, pH 7.4). Protein was then eluted using a linear gradient (8–100%) of buffer B equivalent to 40–400 mM imidazole. Fractions containing targeted protein were pooled, dialyzed against dialysis buffer (40 mM Tris-HCl, 200 mM NaCl and 50% glycerol, pH 7.5) and stored at −20°C prior to use. Purity of the proteins was evaluated by SDS-PAGE and the protein concentration was determined using the Bradford assay. The apparent molecular weights from SDS-PAGE, 12kDa for each protein were consistent with the predicted molecular size of wBmxR1 and wBmxR2 with a C-terminal His-tag.
Rabbit polyclonal anti-VirB8-1 antisera were purchased from Covance Inc., Cell lysates were diluted in 2× Laemmli sample buffer (Sigma Aldrich) and incubated at 96°C for 10 min. 20 μl of samples were subjected to SDS-PAGE using 4–20% Tris-HCl gels (Life Techology) and protein bands were transferred onto a 0.45 μm PVDF membrane using Trans-Blot SD semi-dry transfer cell (Bio-RAD). After blocking for 2 h in 4% milk diluted in Tris-buffered saline (TBS) containing 0.1% Tween, membranes were incubated overnight at 4°C in affinity-purified anti-VirB8-1 antibody diluted 1∶5,000 in blocking buffer. Membranes were washed at least four times in TBS with 0.1% Tween, and then incubated for one hour at room temperature in a 1∶2,000 dilution (TBS with 0.1% Tween) of goat-anti-rabbit-HRP antibody (Cell Signaling Technology). Following additional washing in TBS with 0.1% Tween, the blots were developed using the LumiGLO® reagent (Cell Signaling Technology).
Electrophoretic mobility shift assay (EMSA)
Promoter regions of 9 different genes were amplified by PCR using B. malayi total DNA and Phusion Hot Start Flex DNA Polymerase (NEB M0535). All forward primers were labeled at the 5′end with 6-carboxyfluorescein (FAM). Primer sequences and amplicon sizes for each gene are listed in Table 3. Purified recombinant wBmxR1 and wBmxR2 proteins (0.2 µg) were incubated with each DNA probe (0.1 pmol) for 10 min at room temperature in a 10 µl reaction mixture containing 10 mM Tris-HCl (pH 7.9), 10 mM MgCl2, 50 mM NaCl, 1 mM DTT, 0.1% NP-40 and 0.1 mg/mL calf thymus DNA (Sigma). Samples were then loaded onto 6% DNA retardation gels (Invitrogen) in 0.5×TBE buffer and run at 100 V for 2.5 h at 4°C. FAM-labeled DNA was detected in gels using Typhoon 9400 variable mode imager (GE Healthcare).
Defining the minimal binding sequence of ribA promoter to wBmxR1
Gel shift assays were used to define the minimal binding sequence of the ribA promoter region to wBmxR1. Various sets of primers (Table 4) were designed to amplify specific regions of the promoter. Either the forward or reverse primer was labeled at the 5′ end with FAM. To generate double-stranded DNA from synthesized single-stranded oiligonucleotides, three pairs of complementary oligonucleotide primers were also synthesized and labeled with FAM. Complementary pairs of single strand oligonucleotides (60 nmol of each) were first heated in a heat block at 95°C for 5 min, annealed at room temperature for 1 hour to produce a double stranded DNA probe in vitro in a 50 µl reaction containing 10 mM Tris-HCl (pH7.5), 1 mM EDTA, and 50 mM NaCl. These double-stranded DNA probes were stored at −20°C until use. 0.1 µl of each probe was used in gel shift assays. Binding specificity for each labeled probe was demonstrated using a 50-fold excess of the corresponding unlabeled probe.
Construction of lacZ reporter fusions and β-galactosidase assay
Forward primer gagaGAATTCTGTCTGGAATAACCTGAGACCACG (EcoRI site underlined, additional nucleotides added to facilitate restriction enzyme digestion in lower case) and reverse primer gagaGGATCCGCCTAATTTCGCTGATGGCCCTTT (BamHI site underlined) were used to amplify the promoter region of ribA from B. malayi genomic DNA. The DNA fragment was subsequently cloned into pNK1415  to create a transcriptional fusion vector ribAp-lacZ-pNK1415 with lacZ fusion driven by the ribA promoter. The USER cloning method (NEB) was then utilized to clone the ribAp-lacZ fusion into low copy number plasmid pACYC184 (NEB). The pACYC184 backbone was amplified using PfuTurbo Cx hotstart DNA polymerase (Agilent Technologies) with the primers actttcccUCCAGCAATAGACATAAGCGGCTAT and atgtctccgUTCTTCTTGAGATCGTTTTGGTCTGC derived from pACYC184. The ribAp-lacZ fusion was amplified with primers acggagacaUCGCTCTGCCGGTGGTTACCA and agggaaagUAACCTATAAAAATAGGCGTATCACGAGG derived from the ribAp-lacZ-pNK1415 construct. 10 μl of the ribAp-lacZ insert and 1 μl of the pACYC184 backbone were then incubated with 1 μl of USER enzyme at room temperature for 15 min before being transformed into E. coli cloning strain C3019 (NEB) to generate the ribAp-lacZ-pACYC184 reporter plasmid.
Both ribAp-lacZ-pACYC184 and wBmxR1-pET21a or wBmxR2-pET21a were transformed into E. coli strain C2566 (NEB) for measuring β-galactosidase activity measurement. The pET21a vector alone was used as a negative control. After overnight culture, transformants were sub-cultured at 37°C for 2 hours followed by induction with 0.1 mM IPTG for 3 hours. β–galactosidase activity was determined using a Miller Assay .
Expression of genes of the vitamin B2 (riboflavin) pathway in wBm
The vitamin B2 biosynthesis pathway was reconstructed based on the KEGG database (http://www.genome.jp/kegg). Enzymes that form the pathway include: GTP cyclohydrolase II, pyrimidine deaminase/reductase, 3.4-DHBP synthase, riboflavin synthase α and β chain. The corresponding ORF names in Wolbachia were found based on blast search. To determine gene expression, forward and reverse primers were designed (listed in Table 1) and used in RT-PCR reactions. Female B. malayi adult RNA was used to generate cDNA and used as template.
Culture and treatment of adult B. malayi female worms
Living B. malayi adult female worms were purchased from TRS labs. Worms were washed extensively with RPMI1640 medium prior to culture in RPMI1640 medium supplemented with 2 mM glutamine, 10% Fetal Calf Serum (Gibco) and 100 U/mL streptomycin, 100 mg/mL penicillin, 0.25 mg/mL amphotericin B (Sigma). Four worms were distributed into each well of a 6-well plate and incubated at 37°C, in 5% CO2. After overnight recovery, worms were separated into 4 different groups each containing 12 worms (4 worms/well). Worms incubated in culture media alone (control group) or in culture media containing 0.5 µM doxycycline, 0.5 µM doxycycline plus 10 µg/mL vitamin B2, or 0.5 µM doxycycline plus 2 µg/mL vitamin B2. Culture media were changed daily. Adult worm motility and microfilaria production were recorded daily as described . Motility was scored and expressed as a % of the motility relative to the motility scored on day 0 of the experiment. Microfilariae production was determined at day 7 by counting the number of microfilaria present in 1 mL of spent culture medium. The data obtained from triplicate samples (4 worms in each sample) are expressed as a mean ± standard deviation. The experiment was repeated twice.
Identification of two EcxR homologs in wBm
Using the EcxR sequence (YP_507593.1) to query NCBI databases, two potential homologs, wBmxR1 (wBm0386, YP_198216) and wBmxR2 (wBm0498, YP_198328.1), were identified in Wolbachia from B. malayi. wBmxR1 and wBmxR2 are 300 and 283 bp in length respectively, encoding 99 and 93 amino acid protein, each with a predicted molecular mass of 11 kDa. Two orthologs WD 1304 (NP_967012.1) and WD 0931 (NP_966668.1) were also found in Wolbachia of Drosophila melanogaster (wMel). In addition, a structural ortholog, 2o38_A (gi 122921355), was identified with 99% confidence using the PHYRE program. 2o38_A is a putative XRE family transcriptional regulator present in the alphaproteobacterium Rhodopseudomonas palustris. Alignment of the deduced amino acid sequences of the various orthologs is shown in Fig. 1A. The previously characterized transcription factor ApxR (YP_505110.1) present in Anaplasma phagocytophilum , which is an ortholog of EcxR  was also included in the analysis. Structural analyses indicated that all orthologs share a conserved Helix–Turn–Helix domain that is present in a large family of alpha-helical proteins with a characteristic fold that functions as a sequence-specific DNA binding domain, such as in transcription regulators .
(A) Alignment of the deduced amino acid sequences of EcxR and homologs from wBm (wBmxR1 and wBmxR2), wMel (WD1304 and WD0931), Anaplasma phagocytophilum (ApxR), and Rhodopseudomonas palustris (2o83_A). The alignment was generated using TCOFFEE ClustalW (http://tcoffee.vital-it.ch/cgi-bin/Tcoffee/tcoffee_cgi/index.cgi) and displayed with BOXSHADE (www.ch.embnet.org/software/BOX_form.html). Identical (shaded black) or conserved (grey) amino acids present in at least two of the seven sequences are indicated. The positions of amino acids predicted to form a helix structure and β-strand are shown below the alignment and modeled using the 2o83_A structure. (B) Phylogenetic tree analysis of EcxR and various homologs. Branch length was generated using ClustalW (http://align.genome.jp/sit-bin/clustalw).
Phylogenetic analysis (Fig. 1B) indicates that wBmxR1 and WD1304 are closely related to each other, sharing 77% identity, while wBmxR2 and WD0931 share 76% identity to each other. wBmxR1 is more related to the previously characterized transcription factors, EcxR and ApxR, than wBmxR2. wBmxR1 and wBmxR2 share 45% identity to each other and also share 37% and 44% identity to 2o38_A.
Analysis of wBmxR1 and wBmxR2 expression during the life cycle of B. malayi
Wolbachia have been identified in all developmental stages of B. malayi, from studies on individual worms and isolates from regions endemic for lymphatic filariasis , , . To determine the relative expression of wBmxR1 and wBmxR2 throughout the parasite life cycle, wBmxR1 and wBmxR2 mRNA expression was analyzed by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Relative levels of wBmxR1 and wBmxR2 expression (ratio of wBmxR1 and wBmxR2 to 16S rRNA) were calculated for each RNA sample (Fig. 2). wBmxR1 and wBmxR2 were transcribed in all stages examined (adult female and male worms, microfilariae, third- and fourth-stage larvae) with lowest levels in microfilariae. The expression level of wBmxR1 is comparable to wBmxR2, except in third-stage larvae where wBmxR1 showed 3-fold more expression than wBmxR2. No background was recorded in the assay using samples processed in the absence of reverse transcriptase, indicating the signal obtained was derived from RNA.
RNA from adult female, male, microfilaria, L3 and L4 stages were analyzed by quantitative RT-PCR. The relative gene expression of wBmxR1 and wBmxR2 was represented relative to Wolbachia 16S rRNA. Data were obtained from triplicate samples and expressed as a mean ± standard deviation.
Expression of VirB8 indicates that the Type IV secretion system in wBm is active
Previous genome analysis has indicated the presence of a Type IV secretion system (T4SS) in wBm with two operons and 3 individual genes encoding a total of 14 components. Wolbachia appear to lack certain components of the T4SS namely virB2, virB5 and virB7 , , , . In wBm, virB8-1 (wBm0279), virB9-1 (wBm0280), virB10 (wBm0281), virB11 (wBm0282) and virD4 (wBm0283) are present in operon 1 (Fig. 3A). The Wolbachia surface protein encoded by wsp (wBm0284) is also contained in this operon. Operon 2 contains virB3 (wBm0798), virB4 (wBm0797), virB6-1 (wBm0796), virB6-2 (wBm0795), virB6-3 (wBm0794) and virB6-4 (wBm0793). Three duplicated genes: virB4-2 (wBm0750), virB8-2 (wBm0641) and virB9-2 (wBm0591) are found scattered in the genome. The location of wBmxR1 (wBm0386) and wBmxR2 (wBm0498) were also determined (Fig. 3A). A similar genomic organization is present in E. chaffeensis, except a sodB gene is the first transcribed gene in operon 2 rather than virB3 . In both E. chaffeensis and wBm, ribA is located upstream of operon 1 (Fig. 3A).
(A) Schematic genome map of wBm shown as a circle. The relative locations (shown as closed arrows) of operon 1 (virB8-1, virB9-1, virB10, virB11, virD4, wsp) and the upstream gene ribA, operon 2 (virB3, virB4-1, virB6-1, virB6-2, virB6-3, and virB6-4), virB4-2, virB8-2, virB9-2, wBmxR1, and wBmxR2 are shown. (B) Expression of Wolbachia virB8-1 in various developmental stages of B. malayi. RNA from adult female, male, microfilaria, L3 and L4 stages were analyzed by quantitative RT-PCR. The relative gene expression of virB8-1 is represented relative to Wolbachia 16S rRNA. Data obtained from triplicate samples are expressed as a mean ± standard deviation. (C) Detection of VirB8-1 in protein lysates of adult female worms using anti-VirB8-1 antibody in Western blot analysis. Lane 1, SDS-PAGE gel showing purified recombinant VirB8-1 with an N-terminal His tag and deleted trans-membrane domain (rHis-ΔTM VirB8-1). Western blot analysis using rabbit serum generated against rHis-ΔTM VirB8-1 (lanes 2–5). Lane 2, lysate of E. coli expressing rHis-ΔTM VirB8-1; Lane 3, recombinant full length VirB8-1 with N-terminal His tag (rHis-VirB8-1); Lane 4, recombinant full length VirB8-1 minus tag (rVirB8-1); Lane 5, lysate of female B. malayi worms. Arrows indicate the band corresponding to the VirB8-1 protein.
The VirB8 protein is a critical component of the T4SS and is known to interact with other components of the system . We demonstrated that the T4SS is expressed in wBm since virB8-1 is transcribed in adult female and male worms, microfilariae, third- and fourth-stage larvae, with lowest levels in microfilariae (Fig. 3B). Polyclonal rabbit sera raised against recombinant VirB8-1 (Fig. 3C, lane 1), reacted with lysates from E. coli expressing truncated his-tagged VirB8-1 protein (22 kDa, lane 2), full-length his-tagged protein (29 kDa, lane 3), and full-length VirB8-1 minus tag (27 kDa, lane 4). The additional bands observed may be due to protein degradation, but more likely due to antibody reactivity with E. coli proteins in the crude lysates as they were also found in un-induced E. coli lysates (data not shown). More importantly, the sera recognized a band of the expected size (27 kDa, lane 5) in lysates of adult female worms. The presence of wBmVirB8 indicates that the T4SS is likely active.
Recombinant wBmxR1 and wBmxR2 bind to several promoter regions of wBm T4SS
EcxR binds to five promoter regions of the E. chaffeensis T4SS, located in operon 1 (virB8-1), operon 2 (sodB), virB4-2, virB8-2 and virB9-2 . To determine whether wBmxR1 and wBmxR2 bind to the corresponding promoter regions of wBm, gel shift assays were performed. In addition, the promoter regions upstream of ribA (wBm0278), sodA (wBm0220), wBmxR1 and wBmxR2 were included in the analysis (Fig. 4).
In electrophoretic mobility shift assays (EMSA), FAM-labeled DNA probes derived from the upstream region of ribA, virB8-1, virB3, virB4-2, virB8-2, virB9-2, sodA, wBmxR1 and wBmxR2, and were incubated with (+) or without (–) protein and loaded onto a 6% DNA retardation gel. (A) EMSA using wBmxR1. (B) EMSA using wBmxR2. Arrowheads indicate shifted bands. Bands were visualized using a Typhoon scanner. (C) Summary of the EMSA of wBmxR1 and wBmxR2. The EMSA data from the previously characterized EcxR is included for comparison . Positive gel shift is shown as ‘+’; no gel shift ‘−’; ‘na’, not applicable.
DNA probes derived from the sequence upstream of nine genes were generated by PCR using primers in Table 3 and labeled with FAM at the 5′ end. Electrophoretic mobility shifts assays (EMSA) showed wBmxR1 binds to regions upstream of the virB9-2, ribA, sodA and wBmxR2 genes (Fig. 4A, C), whereas wBmxR2 binds to virB4-2, ribA, and the wBmxR1 promoter regions (Fig. 4B, C). No binding was observed with either protein to the promoter region upstream of virB3, virB8-1, or virB8-2 genes (Fig. 4A and B). Binding of both wBmxR1 and wBmxR2 to the same promoter region was only observed upstream of the ribA gene.
The results of the EMSA studies are summarized in Fig. 4C, and the published data on EcxR is included for comparison. Several differences were observed between E. chaffeensis  and Wolbachia. In E. chaffeensis, EcxR binds to the promoter of the predicted first gene in operon 1, namely virB8-1, whereas both wBmxR1 and wBmxR2 bind to the promoter region of the ribA gene that is located upstream of virB8-1 in wBm. EcxR also binds the promoter of the sodB gene (first gene in operon 2) that encodes superoxide dismutase, while in Wolbachia, sodA (not located in an operon), encodes superoxide dismutase, and its promoter region was found to bind wBmxR1. In addition, EcxR binds to its own promoter (ecxR). However, neither wBmxR1 nor wBmxR2 bound its own promoter. Instead, wBmxR1was found to bind to the promoter upstream of wBmxR2 (Fig. 4A, C), while wBmxR2 binds to the promoter upstream of wBmxR1 (Fig. 4B, C).
ribA located upstream of operon 1 is co-transcribed with virB8-1
Since wBmxR1 and wBmxR2 bind upstream of ribA but not virB8-1, we explored the possibility that ribA is co-transcribed with virB8-1. Using an operon prediction tool (http://www.microbesonline.org), ribA and virB8 were predicted to be located in the same operon in wBm but not in E. chaffeensis. RT-PCR experiments were then performed to determine if the ribA and virB8-1 genes are co-transcribed as one operon in wBm. A forward primer corresponding to ribA and reverse primer corresponding to virB8-1 were used to specifically amplify the intergenenic region between ribA and virB8-1 (Fig. 5A). A 600 bp product was observed using cDNA as a template (Fig. 5B, RT+). No DNA contamination was detected as no amplification was obtained using templates processed in the absence of reverse transcriptase (Fig. 5B, RT−). Therefore in wBm, ribA located upstream of operon 1 is co-transcribed with virB8-1.
cDNA from adult female B. malayi worms was used as the template in PCR reactions. The relative location of the primers (FP, RP) used to detect the intergenic region is shown. (B) Agarose gel showing PCR product resulting from amplification of intergenic region between ribA and virB8-1. Genomic DNA, water, and reverse transcriptase-minus (RT−) samples were included as controls.
The minimal region upstream of ribA that binds wBmxR1
Experiments were then performed to determine the minimal DNA sequence upstream of ribA that is required for binding of wBmxR1. Six DNA fragments corresponding to various regions of the 469 bp promoter region of ribA (Fig. 6A) were generated using a series of specific primers (Table 4) and evaluated in EMSA. Four fragments resulted in positive gel shifts, indicating that binding occurred between –201 to –113 of the promoter (Fig. 6A). To refine the sequence further, three pairs of complementary oligonucleotide primers were then synthesized and annealed to produce various lengths of double-stranded DNA corresponding to the region between –201 to –113 (Fig. 6B). A 50 nt containing probe (probe 2, Fig. 6B) was sufficient to cause positive results in EMSA. Additional mapping of this region from both 5′ and 3′ ends of probe 2, identified a minimal 20 nt long binding sequence (TATATAAAAACTAGAATAAA), located 109 nt upstream of the ATG codon of ribA. wBmxR2 was also found to bind to the same sequence but with less affinity (Fig. 6C). The minimal binding sequence was then used to query the wBm genome to identify additional promoter regions. Several sequences sharing various levels of homology were found, but none were located in predicted promoter regions.
The minimal sequence of the ribA promoter region that binds wBmxR1 was identified an electrophoretic mobility shift assay (EMSA). (A) Six primer sets (A1 to A6 in Table 3) were used to generate six PCR products corresponding to various regions (from the ATG start site of ribA to 469 bp) upstream of the ribA promoter. Each PCR product was incubated with (+) or without (−) protein and loaded onto a 6% DNA retardation gel. (B) Three synthesized 5′FAM-labeled oligos (sequence shown) were annealed to dsDNA and used to shift wBmxR1. (C) wBmxR2 also shifts the minimum binding sequence for wBmxR1 in EMSA.
Recombinant wBmxR1 and wBmxR2 positively regulate a ribAp: lacZ reporter fusion
In order to determine if wBmxR1 and wBmxR2 can activate the expression of ribA, a lacZ reporter fusion was constructed by inserting the promoter region (400 bp) of ribA upstream of the translation start of the promoter-less lacZ gene in pACYC184 (Fig. 7A). β-galactosidase assays were used to measure the transcriptional activity of the lacZ reporter. Following IPTG induction, a significant increase in β-galactosidase activity was detected in the presence of either wBm protein, compared with uninduced samples, or samples prepared from empty vector alone. Western blotting experiments confirmed expression of wBmxR1 and wBmxR2 was only detected following induction with IPTG (data not shown). lacZ reporter fusions were also constructed to determine if wBmxR1 and wBmxR2 can activate expression of virB9-2/sodA, and virB4-2/wBmxR1, respectively. No activation or repression was observed (data not shown).
β–galactosidase assays were used to measure the transcriptional activities of lacZ reporter constructs. E. coli strain C2566 transformed with the reporter plasmid and protein expression vector pET21a, or pwBmxR1, or pwBmxR2 were tested. β–galactosidase assays were performed on induced (IPTG) and un-induced samples. Miller units are shown as mean ± standard deviations from 3 replica experiments. The ribA promoter region containing 400 bp (A) or 20 bp minimal binding sequence (B) were fused to a promoter-less lacZ and cloned into low copy plasmid pACYC184 to generate the reporter plasmid.
Additional experiments were performed to determine if wBmxR1 and wBmxR2 can activate the expression of ribA using the minimal binding sequence identified above (TATATAAAAACTAGAATAAA) fused to the promoter-less lacZ gene (Fig. 7B). Background levels of β-galactosidase activity were substantially lower, and induction of wBmxR1 with IPTG resulted in a significant increase in β-galactosidase activity. However in this case, wBmxR2 which binds this sequence with less affinity (Fig. 6C), did not activate the reporter.
Riboflavin (Vitamin B2) synthesis pathway in wBm
RibA encodes a bifunctional enzyme (3,4-dihydroxy-2-butanone-4-phosphate synthase and GTP cyclohydrolase II) which catalyzes two essential steps in riboflavin (vitamin B2) biosynthesis. In addition to ribA, we identified the remaining four genes in the pathway namely: ribD (wBm0026), ribE (wBm0083), ribC (wBm0185), ribB (wBm0312) indicating that the entire pathway is present in wBm (Fig. 8A). Further analysis was performed on ribA to determine the relative expression of the gene throughout the parasite life cycle. qRT-PCR showed expression of ribA (ratio of ribA to 16S rRNA) in all stages examined (adult female and male worms, microfilariae, third- and fourth-stage larvae) with lowest levels in microfilariae (Fig. 8B). RT-PCR experiments using adult female B. malayi RNA showed ribD, ribE, and ribB genes are also expressed (data not shown).
(A) Schematic diagram of the riboflavin (vitamin B2) biosynthetic pathway. The various enzymes involved in the pathway and their corresponding genes in E. coli and wBm are shown. (B) Wolbachia ribA gene expression in various developmental stages of B. malayi. RNA from adult female, male, microfilaria, L3 and L4 stages were analyzed. ribA expression is represented relative to Wolbachia 16S rRNA. Data obtained from triplicate samples are expressed as a mean ± standard deviation.
Wolbachia likely provide Vitamin B2 to B. malayi host
Genome analysis has indicated that B. malayi lack the entire riboflavin pathway  and it was predicted that a likely source of this essential nutrient is wBm . In order to determine if expression of the Vitamin B2 pathway described above (Fig. 8A) is consistent with an important nutritional role of Wolbachia for the nematode host, B. malayi worms were cleared of Wolbachia infection in culture using doxycycline and then supplemented with vitamin B2 to evaluate if any of the effects of drug treatment could be rescued. It has been shown that elimination of Wolbachia from B. malayi can block embryogenesis and cause parasite death , , .
Adult female B. malayi were cultured in the absence or presence of 0.5 µM doxycycline, or antibiotic supplemented with either 2 µg/mL or 10 µg/mL vitamin B2 (Fig. 9A and 9B). Adult worm motility and microfilaria production were recorded daily as described . Doxycycline treatment resulted in a rapid decrease in motility (Fig. 9A) and microfilaria production (Fig. 9B) compared to untreated control worms. When the culture media were supplemented with 10 µg/mL vitamin B2, adult worm motility and microfilaria production remained at approximately 50% of normal levels. The addition of 2 µg/mL vitamin B2 was not sufficient to rescue the motility (Fig. 9A) or fertility defects (Fig. 9B).
Adult female B. malayi were cultured in the absence (control) or presence of 0.5 µM doxycycline, or antibiotic supplemented with either 2 µg/mL or 10 µg/mL vitamin B2. The motility of worms in vitro was examined daily for 7 days (A). Microfilariae production was determined at day 7 by counting the number of microfilaria present in 1 mL spent culture medium (B). Data obtained from triplicate samples (4 worms in each sample) are expressed as a mean ± standard deviation.
Secretion systems are known to play a number of critical roles in bacteria. As a result they are attractive as potential drug targets for the development of new antibiotics . Many pathogenic intracellular bacteria and bacterial endosymbionts use a type IV secretion system (T4SS) to transport effector molecules (DNA, proteins or DNA-protein complexes) across the membrane into the cytoplasm or nucleus of eukaryotic cells. Agrobacterium tumefaciens, Bartonella spp., Bordetella pertussis, Brucella spp., Helicobacter pylori, and Legionella pneumophila use a T4SS to deliver virulence factors . Amongst obligate intracellular bacteria, the T4SS has been characterized in Rickettsia-like bacteria such as Anaplasma phagocytophila and Ehrlichia chaffeensis , , . It is present and highly conserved in insect , , ,  and nematode Wolbachia , . In wBm, two operons and 3 individual genes (virB4-2, virB8-2 and virB9-2) encode a total of 14 components. VirB8-1, virB9-1, virB10, virB11 and virD4 reside in operon 1, while virB3, virB4, virB6-1, virB6-2, virB6-3 and virB6-4 are found in operon 2. VirB8 is an essential assembly factor for all T4SS and has been considered a suitable target for drugs that inhibit its protein-protein interactions . Recently, specific small molecule inhibitors of Brucella abortus VirB8 were identified in a high-throughput screen and one compound strongly inhibited bacterial proliferation in vivo . Screening efforts to isolate T4SS inhibitors have also led to the discovery of compounds that inhibit Helicobacter pylori VirB11 ATPase activity  and the T4SS mediated transfer of broad-host-range plasmids . We demonstrate here that the T4SS is likely active in wBm since virB8-1 is transcribed in adult female and male worms, microfilariae, third- and fourth-stage larvae. In addition, antibody generated against highly purified recombinant VirB8-1 recognizes a band of the expected size (27 kDa) in lysates of adult female worms. All other components of the wBm T4SS except VirB9-2 have also been detected in proteomic analyses of different stages of B. malayi parasites , further supporting the likelihood that the T4SS is active. Therefore, the discovery of inhibitors of T4SS system of wBm may lead to the development of novel compounds to treat filarial diseases.
Transcription factors that regulate the secretion system components are also attractive as potential drug targets for the development of new antibiotics . In Ehrlichia chaffeensis, a regulator (EcxR) of the T4SS has been identified . We identified two orthologs (wBmxR1 and wBmxR2) in wBm and in the Wolbachia of Drosophila melanogaster (wMel, WD1304 and WD0931). Our analysis of other Wolbachia genomes (wRi, Drosophila simulans; wPip, Culex pipiens; wOo, Onchocerca ochengi; wLs, Litomosoides sigmodontis and wDi, Dirofilaria immitis) revealed the presence of orthologs of both wBmxR1 and wBmxR2 (data not shown). While the majority of wBm genes are expressed in a stage-specific manner , wBmxR1 and wBmxR2 were found to be expressed in both male and female worms as well as in all larval stages examined, which is consistent with important roles for T4SS and vitamin B2 in the biology of Wolbachia. In proteomic analyses of adult worms and microfilariae of B. malayi (not enriched for Wolbachia), wBmxR1 has also been detected .
Interestingly, wBmxR1 and wBmxR2 were found to regulate certain genes of the T4SS and ribA located upstream of virB8-1. RibA encodes a bifunctional enzyme that catalyzes two essential steps in riboflavin (vitamin B2) biosynthesis. Vitamin B2 is an obligatory supplement of human and animal diets, as it serves as the precursor of flavin coenzymes, flavin mononucleotide, and flavin adenine dinucleotide, which are involved in oxidative metabolism and other processes . ribA is present in the virB8-D4 operon in all Wolbachia strains, and also in several Ehrlichia and Anaplasma genomes suggesting that the ribA-virD4 locus may have been present in their common ancestor and important for the integrity and transcriptional activity of the virB8–D4 operon in Anaplasma, Ehrlichia and Wolbachia . Other genes of interest in the virB8–D4 locus include wspB which encodes a Wolbachia surface antigen . wspB has also been shown to be co-transcribed as part of the virB8–D4 operon in 3 Wolbachia strains belonging to A- and B-supergroups , . These studies and our data demonstrate that regulation of the T4SS is variable and complex in different organisms. In wBm, the transcription factors wBmxR1 and wBmxR2 were found to regulate certain genes of the T4SS and the vitamin B2 biosynthesis pathway. Since wBmxR1 and wBmxR2 did not bind to the promoter regions of virB8-2 or the virB genes located in operon 2, it is likely that there are other transcription factors involved in regulation of the T4SS in wBm.
Analysis of the full genome sequence of B. malayi revealed that it lacks the biosynthetic pathway for vitamin B2 . In the present study, we show that the pathway is complete and expressed in wBm. Furthermore, depletion of wBm led to a decrease in adult worm motility and microfilarial production, and the addition of vitamin B2 (10 µg/ml) to the culture partially rescued these effects. Genomic DNA was extracted from treated and untreated parasites and PCR was performed to measure the Wolbachia load. We did not observe a measurable difference between untreated, drug-treated, and vitamin B2 supplemented samples in the time frame of the experiment (data not shown). A similar rescue was reported previously in the Wolbachia/bedbug system, where elimination of Wolbachia in Cimex lecturalis using antibiotics resulted in retarded growth and sterility of the host insect. These deficiencies were rescued by supplementation of B vitamins including vitamin B2 (20 µg/ml) . While the conditions used in these experiments may not exactly mimic the natural environment, these data indicate that Wolbachia strains may supply the essential vitamin to their hosts. Consistent with this is our finding of an intact vitamin B2 biosynthesis pathway in various insect Wolbachia namely: wMel, wRi and wPip (data not shown). Similar analyses of the incomplete genome sequences available from the filarial Wolbachia wLs and wDi, revealed that the pathway is likely functional with the exception of RibA in wLs and RibC in wDi, other enzymes are present. Metabolic provisioning of hosts by endosymbionts is commonly observed in obligate associations , including the supply of vitamin B2 from Buchnera aphidcola to their insect hosts , , . Regarding filarial parasites, wBm has been shown to provide the essential cofactor heme to B. malayi .
While it is likely that several Wolbachia strains can supply vitamin B2 to their hosts, exceptions clearly exist since the recent sequencing of the genome of Wolbachia of Onchocerca ochengi (wOo) has revealed the loss of many features including genes involved in cofactor metabolism, and genes of the riboflavin pathway are either lost or psueodgenized, with the exception of ribA . It will be interesting to understand how O. ochengi obtains Vitamin B2. The same question can be applied to Wolbachia-free filarial parasites such as Loa loa and Acanthocheilonema viteae which are unable to synthesize vitamin B2 de novo. These parasites are presumably dependent on their host for vitamin B2 and other nutrients that may be supplied by the endosymbiont.
The use of antibiotics targeting the Wolbachia endosymbionts of filarial parasites has been validated as an approach for controlling filarial infection in animals and humans. Understanding the molecular and/or biochemical basis of the filaria–Wolbachia relationship and identification of important pathways and proteins involved are required for development of drugs that disrupt the symbiosis. In the case of wOo, rather than nutrient or cofactor provisioning, transcriptome analyses has indicated potential roles of the endosymbiont in energy production and modulation of the mammalian immune response . In our study, we have identified two transcription factors, wBmxR1 and wBmxR2, that co-regulate the T4SS and vitamin B2 pathway in wBm. Given the likely important roles of these regulators in the symbiotic relationship, they warrant further investigation as potential drug targets for the development of new antibiotics for filarial infection.
We gratefully acknowledge encouragement from New England Biolabs and Dr. Donald Comb. We thank William Jack, Larry McReynolds, Barton Slatko, Catherine Poole and Sanjay Kumar for critical reading of the manuscript and helpful comments. We also thank Jim Samuelson for his suggestions in the β–galactosidase assay. Total RNA was obtained from the NIH/NIAID Filariasis Research Reagent Resource Center (www.filariasiscenter.org).
Conceived and designed the experiments: ZL CKC. Performed the experiments: ZL. Analyzed the data: ZL CKC. Contributed reagents/materials/analysis tools: ZL. Wrote the paper: ZL CKC.
- 1. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, et al. (2000) Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355: 1242–1243.
- 2. Hoerauf A, Mand S, Adjei O, Fleischer B, Buttner DW (2001) Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357: 1415–1416.
- 3. Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, et al. (2005) Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet 365: 2116–2121.
- 4. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Albers A, et al. (2011) Macrofilaricidal Activity in Wuchereria bancrofti after 2 Weeks Treatment with a Combination of Rifampicin plus Doxycycline. J Parasitol Res 2011: 201617.
- 5. Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, et al. (2006) Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2: e92.
- 6. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, et al. (2007) Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti. Trop Med Int Health 12: 1433–1441.
- 7. Hoerauf A, Marfo-Debrekyei Y, Buttner M, Debrah AY, Konadu P, et al. (2008) Effects of 6-week azithromycin treatment on the Wolbachia endobacteria of Onchocerca volvulus. Parasitol Res 103: 279–286.
- 8. Mand S, Pfarr K, Sahoo PK, Satapathy AK, Specht S, et al. (2009) Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine. Am J Trop Med Hyg 81: 702–711.
- 9. Jeyaprakash A, Hoy MA (2000) Long PCR improves Wolbachia DNA amplification: wsp sequences found in 76% of sixty-three arthropod species. Insect Mol Biol 9: 393–405.
- 10. Werren JH, Windsor DM (2000) Wolbachia infection frequencies in insects: evidence of a global equilibrium? Proc Biol Sci 267: 1277–1285.
- 11. Bennett GM, Pantoja NA, O'Grady PM (2012) Diversity and phylogenetic relationships of Wolbachia in Drosophila and other native Hawaiian insects. Fly (Austin) 6.
- 12. Zug R, Hammerstein P (2012) Still a host of hosts for Wolbachia: analysis of recent data suggests that 40% of terrestrial arthropod species are infected. PLoS One 7: e38544.
- 13. Sunish IP, Rajendran R, Paramasivan R, Dhananjeyan KJ, Tyagi BK (2011) Wolbachia endobacteria in a natural population of Culex quinquefasciatus from filariasis endemic villages of south India and its phylogenetic implication. Trop Biomed 28: 569–576.
- 14. McGraw EA, O'Neill SL (2004) Wolbachia pipientis: intracellular infection and pathogenesis in Drosophila. Curr Opin Microbiol 7: 67–70.
- 15. Narita S, Kageyama D, Nomura M, Fukatsu T (2007) Unexpected mechanism of symbiont-induced reversal of insect sex: feminizing Wolbachia continuously acts on the butterfly Eurema hecabe during larval development. Appl Environ Microbiol 73: 4332–4341.
- 16. Werren JH (1997) Biology of Wolbachia. Annu Rev Entomol 42: 587–609.
- 17. Alvarez-Martinez CE, Christie PJ (2009) Biological diversity of prokaryotic type IV secretion systems. Microbiol Mol Biol Rev 73: 775–808.
- 18. Llosa M, Roy C, Dehio C (2009) Bacterial type IV secretion systems in human disease. Mol Microbiol 73: 141–151.
- 19. Zechner EL, Lang S, Schildbach JF (2012) Assembly and mechanisms of bacterial type IV secretion machines. Philos Trans R Soc Lond B Biol Sci 367: 1073–1087.
- 20. Christie PJ, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E (2005) Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu Rev Microbiol 59: 451–485.
- 21. Pichon S, Bouchon D, Cordaux R, Chen L, Garrett RA, et al. (2009) Conservation of the Type IV secretion system throughout Wolbachia evolution. Biochem Biophys Res Commun 385: 557–562.
- 22. Masui S, Sasaki T, Ishikawa H (2000) Genes for the type IV secretion system in an intracellular symbiont, Wolbachia, a causative agent of various sexual alterations in arthropods. J Bacteriol 182: 6529–6531.
- 23. Rances E, Voronin D, Tran-Van V, Mavingui P (2008) Genetic and functional characterization of the type IV secretion system in Wolbachia. J Bacteriol 190: 5020–5030.
- 24. Felix C, Pichon S, Braquart-Varnier C, Braig H, Chen L, et al. (2008) Characterization and transcriptional analysis of two gene clusters for type IV secretion machinery in Wolbachia of Armadillidium vulgare. Res Microbiol 159: 481–485.
- 25. Martinez-Nunez C, Altamirano-Silva P, Alvarado-Guillen F, Moreno E, Guzman-Verri C, et al. (2010) The two-component system BvrR/BvrS regulates the expression of the type IV secretion system VirB in Brucella abortus. J Bacteriol 192: 5603–5608.
- 26. de Jong MF, Sun YH, den Hartigh AB, van Dijl JM, Tsolis RM (2008) Identification of VceA and VceC, two members of the VjbR regulon that are translocated into macrophages by the Brucella type IV secretion system. Mol Microbiol 70: 1378–1396.
- 27. Altman E, Segal G (2008) The response regulator CpxR directly regulates expression of several Legionella pneumophila icm/dot components as well as new translocated substrates. J Bacteriol 190: 1985–1996.
- 28. Zusman T, Aloni G, Halperin E, Kotzer H, Degtyar E, et al. (2007) The response regulator PmrA is a major regulator of the icm/dot type IV secretion system in Legionella pneumophila and Coxiella burnetii. Mol Microbiol 63: 1508–1523.
- 29. Cheng Z, Wang X, Rikihisa Y (2008) Regulation of type IV secretion apparatus genes during Ehrlichia chaffeensis intracellular development by a previously unidentified protein. J Bacteriol 190: 2096–2105.
- 30. Kelley LA, Sternberg MJ (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4: 363–371.
- 31. Mathews SA, Volp KM, Timms P (1999) Development of a quantitative gene expression assay for Chlamydia trachomatis identified temporal expression of sigma factors. FEBS Lett 458: 354–358.
- 32. Li Z, Garner AL, Gloeckner C, Janda KD, Carlow CK (2011) Targeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapy. PLoS Negl Trop Dis 5: e1411.
- 33. Simons RW, Houman F, Kleckner N (1987) Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53: 85–96.
- 34. Miller MA, editor (1972) Experiments in Moleculary Genetics: Cold Spring Harbor Laboratory. 352–355 p.
- 35. Rao RU, Moussa H, Weil GJ (2002) Brugia malayi: effects of antibacterial agents on larval viability and development in vitro. Exp Parasitol 101: 77–81.
- 36. Wang X, Kikuchi T, Rikihisa Y (2007) Proteomic identification of a novel Anaplasma phagocytophilum DNA binding protein that regulates a putative transcription factor. J Bacteriol 189: 4880–4886.
- 37. Aravind L, Anantharaman V, Balaji S, Babu MM, Iyer LM (2005) The many faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS Microbiol Rev 29: 231–262.
- 38. Kozek WJ (1977) Transovarially-transmitted intracellular microorganisms in adult and larval stages of Brugia malayi. J Parasitol 63: 992–1000.
- 39. Taylor MJ, Bilo K, Cross HF, Archer JP, Underwood AP (1999) 16S rDNA phylogeny and ultrastructural characterization of Wolbachia intracellular bacteria of the filarial nematodes Brugia malayi, B. pahangi, and Wuchereria bancrofti. Exp Parasitol 91: 356–361.
- 40. McGarry HF, Egerton GL, Taylor MJ (2004) Population dynamics of Wolbachia bacterial endosymbionts in Brugia malayi. Mol Biochem Parasitol 135: 57–67.
- 41. Baron C (2006) VirB8: a conserved type IV secretion system assembly factor and drug target. Biochem Cell Biol 84: 890–899.
- 42. Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, et al. (2007) Draft genome of the filarial nematode parasite Brugia malayi. Science 317: 1756–1760.
- 43. Foster J, Ganatra M, Kamal I, Ware J, Makarova K, et al. (2005) The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode. PLoS Biol 3: e121.
- 44. Debrah AY, Mand S, Marfo-Debrekyei Y, Larbi J, Adjei O, et al. (2006) Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin. Filaria J 5: 1.
- 45. Hoerauf A, Specht S, Marfo-Debrekyei Y, Buttner M, Debrah AY, et al. (2009) Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol Res 104: 437–447.
- 46. Baron C, Coombes B (2007) Targeting bacterial secretion systems: benefits of disarmament in the microcosm. Infect Disord Drug Targets 7: 19–27.
- 47. Ohashi N, Zhi N, Lin Q, Rikihisa Y (2002) Characterization and transcriptional analysis of gene clusters for a type IV secretion machinery in human granulocytic and monocytic ehrlichiosis agents. Infect Immun 70: 2128–2138.
- 48. Rikihisa Y, Lin M, Niu H (2010) Type IV secretion in the obligatory intracellular bacterium Anaplasma phagocytophilum. Cell Microbiol 12: 1213–1221.
- 49. Rikihisa Y, Lin M, Niu H, Cheng Z (2009) Type IV secretion system of Anaplasma phagocytophilum and Ehrlichia chaffeensis. Ann N Y Acad Sci 1166: 106–111.
- 50. Darby AC, Armstrong SD, Bah GS, Kaur G, Hughes MA, et al.. (2012) Analysis of gene expression from the Wolbachia genome of a filarial nematode supports both metabolic and defensive roles within the symbiosis. Genome Res.
- 51. Paschos A, den Hartigh A, Smith MA, Atluri VL, Sivanesan D, et al. (2011) An in vivo high-throughput screening approach targeting the type IV secretion system component VirB8 identified inhibitors of Brucella abortus 2308 proliferation. Infect Immun 79: 1033–1043.
- 52. Fernandez-Lopez R, Machon C, Longshaw CM, Martin S, Molin S, et al. (2005) Unsaturated fatty acids are inhibitors of bacterial conjugation. Microbiology 151: 3517–3526.
- 53. Hilleringmann M, Pansegrau W, Doyle M, Kaufman S, MacKichan ML, et al. (2006) Inhibitors of Helicobacter pylori ATPase Cagalpha block CagA transport and cag virulence. Microbiology 152: 2919–2930.
- 54. Bennuru S, Meng Z, Ribeiro JM, Semnani RT, Ghedin E, et al. (2011) Stage-specific proteomic expression patterns of the human filarial parasite Brugia malayi and its endosymbiont Wolbachia. Proc Natl Acad Sci U S A 108: 9649–9654.
- 55. Abbas CA, Sibirny AA (2011) Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. Microbiol Mol Biol Rev 75: 321–360.
- 56. Wu M, Sun LV, Vamathevan J, Riegler M, Deboy R, et al. (2004) Phylogenomics of the reproductive parasite Wolbachia pipientis wMel: a streamlined genome overrun by mobile genetic elements. PLoS Biol 2: E69.
- 57. Hosokawa T, Koga R, Kikuchi Y, Meng XY, Fukatsu T (2010) Wolbachia as a bacteriocyte-associated nutritional mutualist. Proc Natl Acad Sci U S A 107: 769–774.
- 58. Zientz E, Dandekar T, Gross R (2004) Metabolic interdependence of obligate intracellular bacteria and their insect hosts. Microbiol Mol Biol Rev 68: 745–770.
- 59. Lamelas A, Gosalbes MJ, Manzano-Marin A, Pereto J, Moya A, et al. (2011) Serratia symbiotica from the aphid Cinara cedri: a missing link from facultative to obligate insect endosymbiont. PLoS Genet 7: e1002357.
- 60. Nakabachi A, Ishikawa H (1999) Provision of riboflavin to the host aphid, Acyrthosiphon pisum, by endosymbiotic bacteria, Buchnera. J Insect Physiol 45: 1–6.
- 61. Bermingham J, Rabatel A, Calevro F, Vinuelas J, Febvay G, et al. (2009) Impact of host developmental age on the transcriptome of the symbiotic bacterium Buchnera aphidicola in the pea aphid (Acyrthosiphon pisum). Appl Environ Microbiol 75: 7294–7297.
- 62. Wu B, Novelli J, Foster J, Vaisvila R, Conway L, et al. (2009) The heme biosynthetic pathway of the obligate Wolbachia endosymbiont of Brugia malayi as a potential anti-filarial drug target. PLoS Negl Trop Dis 3: e475.